These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3366514)
1. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Lenders JW; Demacker PN; Vos JA; Jansen PL; Hoitsma AJ; van 't Laar A; Thien T Int J Sports Med; 1988 Feb; 9(1):19-23. PubMed ID: 3366514 [TBL] [Abstract][Full Text] [Related]
2. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders. Kuipers H; Wijnen JA; Hartgens F; Willems SM Int J Sports Med; 1991 Aug; 12(4):413-8. PubMed ID: 1917227 [TBL] [Abstract][Full Text] [Related]
3. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal. Hartgens F; Kuipers H; Wijnen JA; Keizer HA Int J Sports Med; 1996 Aug; 17(6):429-33. PubMed ID: 8884417 [TBL] [Abstract][Full Text] [Related]
4. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids. Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436 [TBL] [Abstract][Full Text] [Related]
5. Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders. Zuliani U; Bernardini B; Catapano A; Campana M; Cerioli G; Spattini M Int J Sports Med; 1989 Feb; 10(1):62-6. PubMed ID: 2495256 [TBL] [Abstract][Full Text] [Related]
6. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Webb OL; Laskarzewski PM; Glueck CJ Metabolism; 1984 Nov; 33(11):971-5. PubMed ID: 6493049 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
8. Lipid profile of body builders with and without self-administration of anabolic steroids. Fröhlich J; Kullmer T; Urhausen A; Bergmann R; Kindermann W Eur J Appl Physiol Occup Physiol; 1989; 59(1-2):98-103. PubMed ID: 2583156 [TBL] [Abstract][Full Text] [Related]
9. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk. Dickerman RD; McConathy WJ; Zachariah NY J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
11. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives. Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552 [TBL] [Abstract][Full Text] [Related]
12. Lipoproteins status in professional football players after period of vacation and one month after a new intensive training program. Tater D; Leglise D; Person B; Lambert D; Bercovici JP Horm Metab Res; 1987 Jan; 19(1):24-7. PubMed ID: 3557279 [TBL] [Abstract][Full Text] [Related]
13. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
15. Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders. Deyssig R; Weissel M J Clin Endocrinol Metab; 1993 Apr; 76(4):1069-71. PubMed ID: 8473383 [TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678 [TBL] [Abstract][Full Text] [Related]
18. [Anabolic steroids: damages, effect on performance, and on metabolism (author's transl)]. Keul J; Deus B; Kindermann W Med Klin; 1976 Mar; 71(12):497-503. PubMed ID: 1263996 [TBL] [Abstract][Full Text] [Related]
19. Postoperative course and anabolic-androgenic steroid abuse -- a case report. Medras M; Tworowska U; Jozkow P; Dumanski A; Dubinski A Anaesthesia; 2005 Jan; 60(1):81-4. PubMed ID: 15601278 [TBL] [Abstract][Full Text] [Related]
20. Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency. Graham MR; Baker JS; Evans P; Kicman A; Cowan D; Hullin D; Thomas N; Davies B Horm Res; 2008; 69(6):343-54. PubMed ID: 18504393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]